Adapthealth Corp (AHCO) Cash Flow Statement
A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments.
Total Cash From Operating Activities Chart for Adapthealth Corp
Adapthealth Corp (AHCO) operating cash flow for FY2025 was USD 601.8M, a 11.1% change from FY2024. Adapthealth Corp's operating cash flow grew from USD 29.9M in 2016 to USD 601.8M in 2025 (1910.2% over 9 years). Operating cash flow compound annual growth rate: 5-year CAGR of 25.2%.
Total Cash From Operating Activities (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $803.12M
- Implied Share Price
- $6.02
- Enterprise Value
- $2.81B
- Revenue (TTM)
- $3.36B
- EBITDA
- $583.47M
- Profit Margin
- -6.79%
- Trailing P/E
- —
- Forward P/E
- 7.78
- Price/Book (MRQ)
- 0.57
- Price/Sales (TTM)
- 0.24
- EV/EBITDA
- 9.73
- EV/Revenue
- 0.84
- Dividend Yield
- —
- Book Value
- $10.34
- Free Cash Flow (FY2025)
- $219.38M
- Free Cash Flow Yield
- 27.32%
Snapshot as of 25th October 2026 — not point-in-time controlled, may lag the live market by a few days.